Related references
Note: Only part of the references are listed.Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial
Rodney P. E. Pollard et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Contribution of antiferritin antibodies to diagnosis of giant cell arteritis
Alexis Regent et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Regulatory B cells in ANCA-associated vasculitis
B. Wilde et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Progranulin antibodies in autoimmune diseases
Lorenz Thurner et al.
JOURNAL OF AUTOIMMUNITY (2013)
Immune mechanisms in medium and large-vessel vasculitis
Cornelia M. Weyand et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab
Bimba F. Hoyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumaticae
N. T. Baerlecken et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis
Maxime Samson et al.
ARTHRITIS AND RHEUMATISM (2012)
IgM+IgD+CD27+B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients
Sandra Weller et al.
BLOOD (2012)
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
Tom A. Barr et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Soluble BAFF Levels Inversely Correlate with Peripheral B Cell Numbers and the Expression of BAFF Receptors
Matthias Kreuzaler et al.
JOURNAL OF IMMUNOLOGY (2012)
Advances in human B cell phenotypic profiling
Denise A. Kaminski et al.
FRONTIERS IN IMMUNOLOGY (2012)
B Cell Reconstitution and T Helper Cell Balance After Rituximab Treatment of Active Primary Sjogren's Syndrome A Double- Blind, Placebo-Controlled Study
W. H. Abdulahad et al.
ARTHRITIS AND RHEUMATISM (2011)
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
Yohei Iwata et al.
BLOOD (2011)
B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency
Gertjan J. Driessen et al.
BLOOD (2011)
Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways
Magdalena A. Berkowska et al.
BLOOD (2011)
Temporal Small-Vessel Inflammation in Patients with Giant Cell Arteritis: Clinical Course and Preliminary Immunohistopathologic Characterization
Elise Belilos et al.
JOURNAL OF RHEUMATOLOGY (2011)
Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach
Alexis Regent et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjogren's syndrome
Keiko Yoshimoto et al.
ARTHRITIS RESEARCH & THERAPY (2011)
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Gene G. Hunder et al.
ARTHRITIS AND RHEUMATISM (2010)
Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells
Anouk Caraux et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Paul A. Blair et al.
IMMUNITY (2010)
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effector and regulatory B cells: modulators of CD4+ T cell immunity
Frances E. Lund et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Epidemiology of Giant Cell Arteritis and Polymyalgia Rheumatica
Miguel A. Gonzalez-Gay et al.
ARTHRITIS CARE & RESEARCH (2009)
Polymyalgia rheumatica and giant-cell arteritis
Carlo Salvarani et al.
LANCET (2008)
A role for BLyS in the activation of innate immune cells
Sock Kyung Chang et al.
BLOOD (2006)
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
Therese Vallerskog et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis
A Bhatia et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Antigen-specific memory B cell development
LJ McHeyzer-Williams et al.
ANNUAL REVIEW OF IMMUNOLOGY (2005)
Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus
W Stohl et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Lymphocyte subset numbers depend on the bacterial origin of sepsis
M Holub et al.
CLINICAL MICROBIOLOGY AND INFECTION (2003)
Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica
R Schmits et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Reciprocal regulation of polarized cytokine production by effector B and T cells
DP Harris et al.
NATURE IMMUNOLOGY (2000)